IP Library Granted Patent US 11,814,615
Granted Patent B2
US 11,814,615 · App. 17/822,860 · Granted Nov 14, 2023

Methods and compositions for preserving bacteria

Inventors: Daniel E. Couto (Concord, MA); Shilpa Reddy (Watertown, MA); Jil Ulrich (Medford, MA); Scott Michonski (Belmont, MA)
Assignee: Vedanta Biosciences, Inc.
C12N1/04C12N1/20C12Q1/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,814,615
App. No.
17/822,860
Granted
Nov 14, 2023
Kind
B2
Abstract

The disclosure provides methods and compositions for the preservation of bacteria.

Claims (24)

1. A method for preserving bacteria, the method comprising:

(i) adding bacteria to a composition comprising a disaccharide, yeast extract, cysteine, sodium metabisulfite, and a histidine buffer; and

(ii) subjecting the composition comprising the bacteria to a lyophilization cycle.

2. The method of claim 1 , wherein the lyophilization cycle comprises one or more steps of a temperature ramp rate between 0.5° C./min to 3° C./min.

3. The method of claim 2 , wherein the temperature ramp rate is 1° C./min.

4. The method of claim 2 , wherein the temperature ramp rate is 2.5° C./min.

5. The method of claim 1 , wherein the method further comprises measuring the number of colony forming units after subjecting the composition comprising the bacteria to the lyophilization cycle.

6. The method of claim 5 , wherein the method further comprises measuring the number of colony forming units prior to subjecting the composition comprising the bacteria to the lyophilization cycle.

7. The method of claim 6 , wherein the method further comprises:

comparing the number of colony forming units prior to subjecting the composition comprising the bacteria to the lyophilization cycle and the number of colony forming units after subjecting the composition comprising the bacteria to the lyophilization cycle; and

determining a percentage of recovered colony forming units of the bacteria after the lyophilization cycle.

8. The method of claim 1 , wherein the composition maintains viability of one or more bacterial strains upon lyophilization.

9. The method of claim 1 , wherein the method allows for recovery of at least 10% of colony forming units of the bacteria over a period of time.

10. The method of claim 9 , wherein the period of time is at least 2 weeks.

11. The method of claim 1 , wherein the method allows for recovery of at least 10% of colony forming units of the bacteria after a freeze-thaw cycle.

12. The method of claim 1 , wherein the method allows for recovery of at least 10% of colony forming units of the bacteria after the lyophilization cycle.

13. The method of claim 1 , wherein the bacteria comprise one or more bacterial strains belonging to the class Clostridia.

14. The method of claim 1 , wherein the bacteria comprise one or more bacterial strains belonging to the family Clostridiaceae.

15. The method of claim 1 , wherein the bacteria comprise one or more bacterial strains belonging to Clostridium clusters IV and/or XIVa.

16. The method of claim 1 , wherein the bacteria comprise one or more bacterial strains belonging to species selected from the group consisting of Clostridium bolteae, Anaerotruncus colihominis, Ruminococcus torques, Clostridium symbiosum, Blautia producta, Dorea longicatena, Erysipelotrichaceae bacterium and Subdolinogranulum spp.

17. The method of claim 1 , wherein the disaccharide is trehalose.

18. The method of claim 17 , wherein the composition comprises about 7.5% trehalose, about 1% yeast extract, about 0.05% cysteine, about 0.05% sodium metabisulfite, and about 20 mM histidine buffer.

19. The method of claim 1 , wherein the disaccharide is sucrose.

20. The method of claim 19 , wherein the composition comprises 7.0% sucrose, 1% yeast extract, 0.05% cysteine, 0.05% sodium metabisulfite, and 20 mM histidine buffer.

Assignments (4)
SECURITY INTEREST Recorded Jul 7, 2025
From: VEDANTA BIOSCIENCES, INC.
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE
Reel/Frame 071622/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: COUTO, DANIEL E.; REDDY, SHILPA; ULRICH, JIL; MICHONSKI, SCOTT
To: VEDANTA BIOSCIENCES, INC.
Reel/Frame 064545/0376 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2023
From: OXFORD FINANCE LLC
To: VEDANTA BIOSCIENCES, INC.
Reel/Frame 063440/0569 →
SECURITY INTEREST Recorded Dec 12, 2022
From: VEDANTA BIOSCIENCES, INC.
To: OXFORD FINANCE LLC
Reel/Frame 062115/0411 →
Continuity (3)
Continuation 16341583
Provisional Application 62414489 · Oct 28, 2016
Related Publication 20230159883A1 · May 25, 2023
Cited By (1)
US 12,460,175